2024 marked a year of significant progress for Freemelt as we advanced towards our strategic goal of establishing additive manufacturing as an industrial standard within our three focus segments: defense, energy, and MedTech. We have delivered our first industrial machine, expanded our project portfolio, and strengthened our position in a market where the demand for high-performance materials and efficient production methods is increasing. This demand is primarily driven by the geopolitical situation and the ongoing energy transition, driving interest in our technology from the defense industry, as well as key players in fusion and MedTech. With a growing pipeline of paid development projects and several ongoing proof-of-concept projects, we strengthen our position and increase the potential for future industrial volume orders.

The most notable events during 2024 are the strategic agreements we signed with two global OEMs (Original Equipment Manufacturer) to demonstrate serial production of orthopedic implants using our industrial machine, eMELT. These collaborations represent significant commercial breakthroughs and position us as a key player in additive manufacturing of orthopedic implants. Additionally, we have deepened our collaboration with Saab Dynamics on defense applications, further confirming the value our technology brings to the development of high-performance, complex applications. In the energy sector, we have increased our customer engagement, leading to a new project order from UKAEA (United Kingdom Atomic Energy Authority) in February 2025 for large-scale production tests of 3D printed tungsten tiles for fusion reactors. UKAEA has also ordered an eMELT machine valued at SEK 8 million to manufacture tungsten tiles.

The Annual Report is available in Swedish as an attached PDF and at Freemelt’s website: Årsredovisning